Published in Pathol Int on May 10, 2012
Biliary Adenofibroma with Invasive Carcinoma: Case Report and Review of the Literature. Case Rep Pathol (2016) 0.87
Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor. J Gastrointest Oncol (2016) 0.75
Effect of vitamin K2 on the recurrence of hepatocellular carcinoma. Hepatology (2011) 3.00
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma. Hum Pathol (2012) 2.27
Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int (2009) 1.82
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol (2006) 1.63
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. J Gastroenterol (2010) 1.57
Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol (2003) 1.56
Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays. Pathol Res Pract (2005) 1.51
Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. Ann Surg Oncol (2005) 1.47
Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene (2003) 1.47
Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Pathol Int (2002) 1.46
Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2. Hepatology (2003) 1.45
Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma. Mod Pathol (2011) 1.38
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol (2006) 1.32
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett (2002) 1.29
Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. Int J Cancer (2006) 1.28
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol (2012) 1.27
Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum (2004) 1.12
Aggressive angiomyxoma of the oral floor: report of a case. J Oral Maxillofac Surg (2004) 1.12
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer (2002) 1.09
Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int (2006) 1.09
The Critical Impact of HIF-1a on Gastric Cancer Biology. Cancers (Basel) (2013) 1.08
The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling. Ann Surg Oncol (2007) 1.07
Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci (2008) 1.07
Lineage specificity of gene expression patterns. Proc Natl Acad Sci U S A (2004) 1.07
Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene (2004) 1.06
Multiple inflammatory pseudotumor of the liver, mimicking cholangiocarcinoma with tumor embolus in the hepatic vein: report of a case. Surg Today (2007) 1.05
Intrahepatic multicystic biliary hamartoma: report of a case. Hepatol Res (2008) 1.04
A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol (2009) 1.03
Signet ring cell carcinoma of the lower bile duct with rapid growth: report of a case. Hepatogastroenterology (2008) 1.03
Gastrointestinal function and quality of life after pylorus-preserving pancreatoduodenectomy. J Hepatobiliary Pancreat Surg (2006) 1.03
Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma. Oncol Rep (2008) 1.02
Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis. Clin Cancer Res (2008) 1.02
Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J Gastroenterol (2004) 1.02
Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol (2010) 1.02
Clinico-pathological characteristics of p63 expression in B-cell lymphoma. Cancer Sci (2006) 1.01
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res (2007) 1.00
Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma. J Surg Oncol (2008) 1.00
The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. J Gastroenterol (2006) 1.00
Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatol Res (2010) 0.99
Biological role and prognostic significance of NAC1 in ovarian cancer. Gynecol Oncol (2010) 0.99
Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int J Cancer (2009) 0.99
Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin Cancer Res (2004) 0.98
A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer. Clin Cancer Res (2008) 0.98
Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line. Cancer Chemother Pharmacol (2003) 0.98
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatol Res (2015) 0.98
Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci (2007) 0.98
Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep (2008) 0.97
Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib. Hepatol Res (2012) 0.97
Outcomes of patients with spontaneous rupture of hepatocellular carcinoma. Hepatogastroenterology (2011) 0.96
Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol (2009) 0.96
Low serum albumin level is risk factor for patients with percutaneous endoscopic gastrostomy. Intern Med (2010) 0.96
HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer (2010) 0.96
Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas. Hum Pathol (2011) 0.96
Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr (2007) 0.95
Iliac lymph node metastasis of an unknown primary tumor: report of a case. Surg Today (2006) 0.94
Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. J Neurooncol (2006) 0.94
Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. J Gastroenterol (2007) 0.94
Endoscopic hemostasis for bleeding gastric varices treated by combination of variceal ligation and sclerotherapy with N-butyl-2-cyanoacrylate. J Gastroenterol (2007) 0.93
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma. Cancer (2011) 0.93
Beta 1-integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen-activated protein kinase dependent pathway. Cancer (2002) 0.93
Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. Am J Physiol Heart Circ Physiol (2006) 0.93
Adenoid cystic carcinoma of the lacrimal gland with wide and severe myoepithelial differentiation. Auris Nasus Larynx (2002) 0.92
Maternal thyroid function during pregnancy and puerperal period. Endocr J (2005) 0.92
Influence of ovarian cystectomy on the ovulatory function of the residual ovary. Eur J Obstet Gynecol Reprod Biol (2005) 0.92
Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer. Am J Clin Pathol (2012) 0.91
Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. Gynecol Oncol (2010) 0.91
Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Int J Cancer (2003) 0.91
Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol (2002) 0.90
Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a prognostic factor in human endometrial carcinoma. Gynecol Oncol (2005) 0.90
Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study. J Atheroscler Thromb (2006) 0.90
Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int (2002) 0.90
Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer. Ann Surg Oncol (2009) 0.89
Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci (2007) 0.89
Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1. Hepatol Res (2003) 0.89
Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen. Clin Cancer Res (2009) 0.89
NAC1, a potential stem cell pluripotency factor expression in normal endometrium, endometrial hyperplasia and endometrial carcinoma. Int J Oncol (2010) 0.89
Inhibition of endothelial cell proliferation, in vitro angiogenesis, and the down-regulation of cell adhesion-related genes by genistein. Combined with a cDNA microarray analysis. Endothelium (2006) 0.88
Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread. World J Gastroenterol (2010) 0.88
Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer. Hum Pathol (2012) 0.88
Percutaneous transhepatic portal embolization for persistent bile leakage after hepatic resection: report of a case. Surg Today (2008) 0.88
Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients. World J Gastroenterol (2011) 0.88
Glucose intolerance in Japanese patients with polycystic ovary syndrome. Arch Gynecol Obstet (2006) 0.88
Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Hum Pathol (2002) 0.88
Mechanisms of ovarian cancer metastasis: biochemical pathways. Int J Mol Sci (2012) 0.88